FRYL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.136400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.877200E-01
Normal-vs-Stage2
6.504200E-01
Normal-vs-Stage3
1.794250E-01
Normal-vs-Stage4
9.070800E-01
Stage1-vs-Stage2
9.936200E-01
Stage1-vs-Stage3
2.926300E-02
Stage1-vs-Stage4
8.155000E-01
Stage2-vs-Stage3
9.214000E-02
Stage2-vs-Stage4
7.805200E-01
Stage3-vs-Stage4
1.838840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.099400E-01
Normal-vs-AfricanAmerican
7.660000E-01
Normal-vs-Asian
5.612000E-01
Caucasian-vs-AfricanAmerican
9.051000E-01
Caucasian-vs-Asian
6.553800E-01
AfricanAmerican-vs-Asian
7.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.500000E-01
Normal-vs-Female
5.702400E-01
Male-vs-Female
9.922600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.313000E-01
Normal-vs-Age(41-60Yrs)
8.895200E-01
Normal-vs-Age(61-80Yrs)
5.556000E-01
Normal-vs-Age(81-100Yrs)
3.519200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.114800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.070200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.973000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.980000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.916000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.999000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.828400E-01
Normal-vs-Daily Drinker
3.938200E-01
Normal-vs-Weekly Drinker
2.685200E-01
Normal-vs-Occasional Drinker
7.381200E-01
Normal-vs-Social Drinker
9.827000E-01
Non Drinker-vs-Daily Drinker
6.066200E-01
Non Drinker-vs-Weekly Drinker
3.546800E-01
Non Drinker-vs-Occasional Drinker
6.294200E-01
Non Drinker-vs-Social Drinker
4.249400E-01
Daily Drinker-vs-Weekly Drinker
5.129400E-01
Daily Drinker-vs-Occasional Drinker
2.356600E-01
Daily Drinker-vs-Social Drinker
2.369200E-01
Weekly Drinker-vs-Occasional Drinker
8.437600E-02
Weekly Drinker-vs-Social Drinker
1.232580E-01
Occasional Drinker-vs-Social Drinker
6.353400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.016380E-01
Normal-vs-Grade 2
5.552000E-02
Normal-vs-Grade 3
5.695500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.811400E-01
Grade 1-vs-Grade 3
3.121400E-01
Grade 1-vs-Grade 4
1.016380E-01
Grade 2-vs-Grade 3
1.437960E-01
Grade 2-vs-Grade 4
5.552000E-02
Grade 3-vs-Grade 4
5.695500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.681000E-01
Normal-vs-NonDiabetic
5.478600E-01
Diabetic-vs-NonDiabetic
3.912000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.189600E-01
Normal-vs-NoPancreatitis
5.412200E-01
Pancreatitis-vs-NoPancreatitis
8.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.249800E-01
Normal-vs-N1
6.264800E-01
N0-vs-N1
7.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.201400E-01
Normal-vs-TP53-NonMutant
8.522800E-01
TP53-Mutant-vs-TP53-NonMutant
3.061000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
